Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study. - Wikidata - awgldk - TriplyDB

Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study.

Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study.

http://www.wikidata.org/entity/Q34080807

about

Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy Epigenetic regulators and their impact on therapy in acute myeloid leukemia Rare Cytogenetic Abnormalities and Alteration of microRNAs in Acute Myeloid Leukemia and Response to Therapy Systematic Classification of Mixed-Lineage Leukemia Fusion Partners Predicts Additional Cancer Pathways Pediatric AML: From Biology to Clinical Management Recent progress toward epigenetic therapies: the example of mixed lineage leukemia How I treat pediatric acute myeloid leukemia Childhood acute myeloid leukaemia Current Management of Childhood Acute Myeloid Leukemia.Strategies for reducing the treatment-related physical burden of childhood acute myeloid leukaemia - a review.MLL rearrangements impact outcome in HOXA-deregulated T-lineage acute lymphoblastic leukemia: a Children's Oncology Group Study.Discovering and understanding oncogenic gene fusions through data intensive computational approaches Chromatin modifications as therapeutic targets in MLL-rearranged leukemia.Mixed lineage leukemia-septin 5 fusion transcript in de novo adult acute myeloid leukemia with t(11;22)(q23;q11.2): A case report Role of misfolded N-CoR mediated transcriptional deregulation of Flt3 in acute monocytic leukemia (AML)-M5 subtype.Prognostic significance of 11q23 aberrations in adult acute myeloid leukemia and the role of allogeneic stem cell transplantation.Histone H3 lysine 79 methyltransferase Dot1 is required for immortalization by MLL oncogenes.Development of five dual-color, double-fusion fluorescence in situ hybridization assays for the detection of common MLL translocation partners The MLL recombinome of acute leukemias in 2013.Prognostic factors in children with acute myeloid leukaemia and excellent response to remission induction therapy.Biology, risk stratification, and therapy of pediatric acute leukemias: an update.Pediatric acute myeloid leukemia with t(8;16)(p11;p13), a distinct clinical and biological entity: a collaborative study by the International-Berlin-Frankfurt-Munster AML-study group.ARID5B polymorphism confers an increased risk to acquire specific MLL rearrangements in early childhood leukemia.Prognostic significance of additional cytogenetic aberrations in 733 de novo pediatric 11q23/MLL-rearranged AML patients: results of an international study mll ortholog containing functional domains of human MLL is expressed throughout the zebrafish lifespan and in haematopoietic tissues Integrative analysis of type-I and type-II aberrations underscores the genetic heterogeneity of pediatric acute myeloid leukemia Gene expression profiles associated with pediatric relapsed AML.Vandetanib mediates anti-leukemia activity by multiple mechanisms and interacts synergistically with DNA damaging agents.The role of matched sibling donor allogeneic stem cell transplantation in pediatric high-risk acute myeloid leukemia: results from the AML-BFM 98 study.Subtype prediction in pediatric acute myeloid leukemia: classification using differential network rank conservation revisited Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia.Heterogeneous cytogenetic subgroups and outcomes in childhood acute megakaryoblastic leukemia: a retrospective international study FuGePrior: A novel gene fusion prioritization algorithm based on accurate fusion structure analysis in cancer RNA-seq samples.Does hematopoietic stem cell transplantation benefit infants with acute leukemia?Cell of origin determines clinically relevant subtypes of MLL-rearranged AML Molecular monitoring of minimal residual disease in two patients with MLL-rearranged acute myeloid leukemia and haploidentical transplantation after relapse.Advances in paediatric cancer treatment Leukemic transformation by the MLL-AF6 fusion oncogene requires the H3K79 methyltransferase Dot1l.High EVI1 expression is associated with MLL rearrangements and predicts decreased survival in paediatric acute myeloid leukaemia: a report from the children's oncology group.MLL fusion protein-driven AML is selectively inhibited by targeted disruption of the MLL-PAFc interaction.

P2860

Q26746038-A1476C05-6724-4D02-B824-65FB971141C6 Q26765402-C99F7863-D91C-4762-9F20-18A99F882E84 Q26771425-AC555975-90EB-444B-B5F2-87B8EBACAB0E Q26771880-3F9E84B7-06D8-48AE-8C8F-AC52A31F5C14 Q26799773-D79E8E35-8484-4392-95CE-90AD084A796D Q26863577-98E3BD57-4AE9-4A3A-8701-8FF1B1C91026 Q26992280-845D9018-D29D-481D-B6AA-74D3FD0E7594 Q27005960-0F090FCE-854B-439F-8FE0-38411B59158E Q30244036-43E96231-28CB-4D4E-B4EA-265C17443243 Q30244244-97F70438-240E-41DE-9F4B-B362CC1083EB Q30277191-009CA634-0528-402C-BDB9-830AD63C3AB8 Q31083417-9F845269-0B38-423E-8285-ABFE7A3C3B9A Q33666543-D081E9C0-94ED-4FB1-AAE7-3675691C65F1 Q33727691-EEB17C14-A861-42C4-8FBA-8AF39EA6BBB7 Q34238553-A2946B8C-C725-4C1B-ACC7-0A2DF7E94105 Q34273628-3DC4AB0A-6EC8-4CC3-8AD7-69BDE38F091F Q34581540-EDBF44C4-8ABC-4162-9179-E7FA3467C518 Q34620470-1B8DF26F-67D0-4BDF-95CF-A0894147AFD8 Q34651113-B90BE23C-F415-41D6-9B2C-81C66AB5348E Q34674124-62FF078F-2BB0-49B0-9B9E-9C68F246B4C7 Q34764504-410EDB7D-F531-459C-9FD2-14FF116B0B4A Q35040531-2B4105A7-0386-495A-BEA7-94052D9A3590 Q35101250-518DADE8-EDB5-4701-A210-2D99D0995DC3 Q35127974-E677C213-A385-417A-A0D1-FD262993E844 Q35172438-4B259CBE-CA1D-4AD6-A97A-8CD064DA1CBD Q35265916-4373CFAB-467F-4FF1-8B40-8B9461FFC5C6 Q35302035-0C6F1326-A042-4F0A-8F20-6D51AB901DDB Q35569079-8E1EFA5E-4701-4AAD-B061-BC126599CFEF Q35643005-8E1D61AB-A0EB-4D9F-A8C4-60D9DE5E08C4 Q35785820-64554519-85CE-46CC-9743-C72EFDA9710B Q36053792-38BBEAA5-5A65-456D-9C81-2D806B97A5F9 Q36091293-53A6AE92-9FA1-4248-811B-E4EC21F8A3B0 Q36257816-E3BA5A80-B950-4983-9406-9C7482FF30DD Q36318780-3CBDB1EE-42DA-4482-B653-E68D2D0B8B5E Q36409664-755CFB59-1D5B-4CF8-BB1C-D900A466455B Q36444440-F5CC5497-1CB3-4C18-9434-7FAA0CB7E931 Q36508630-B6D07241-B74F-4A24-A96C-648FAA7979A8 Q36730426-33F34F55-EC8D-4B39-95E5-619A979FD53A Q37125803-0FEF686D-721D-43B3-9115-AE10A2DACBCD Q37169100-BFD7ACCC-E055-41C7-BE21-5B9D24A8944E

P2860

Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study.

http://www.wikidata.org/entity/Q34080807

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Novel prognostic subgroups in ...... rnational retrospective study.

@ast

Novel prognostic subgroups in ...... rnational retrospective study.

@en

Novel prognostic subgroups in ...... rnational retrospective study.

@nl

type

label

Novel prognostic subgroups in ...... rnational retrospective study.

@ast

Novel prognostic subgroups in ...... rnational retrospective study.

@en

Novel prognostic subgroups in ...... rnational retrospective study.

@nl

prefLabel

Novel prognostic subgroups in ...... rnational retrospective study.

@ast

Novel prognostic subgroups in ...... rnational retrospective study.

@en

Novel prognostic subgroups in ...... rnational retrospective study.

@nl

P1433

Q34080807-8C36ACBA-5A63-4E41-9AFD-F0767BC47F3A

P1476

Q34080807-5C8F5677-054C-49D9-B0F5-3704D1685CB1

P2093

Q34080807-02DEF6B8-5622-4AC5-B75E-5AADEB2E0ECB

Q34080807-073DE9D7-023C-43C7-91A4-9BA3D76EC5BB

Q34080807-10510E57-1C06-4BFF-9921-DA5A944594AC

Q34080807-159C8E1C-8DE4-4708-A2DB-3D4DFB8E3B42

Q34080807-1E84607F-5482-4FED-99E3-9FAA749145EE

Q34080807-21B8537B-291F-4A6E-81C3-2B3401D00066

Q34080807-230B94BB-5CA7-4A21-ACAF-EF8BA6FFEAE2

Q34080807-230E4489-802B-42B6-A8FF-E7323BB89E13

Q34080807-2D27ADA5-2455-49E9-B588-F6E0F1B16F8A

Q34080807-330CEB4B-D658-4358-BE32-C7687104A9F5

P2860

Q34080807-0BC33F98-0005-40F6-A877-DD32C90C65CD

Q34080807-21CAD3D5-3F68-46CF-89EC-005F3C701013

Q34080807-29793F49-B35A-41D2-9C0D-D00249F86FBC

Q34080807-2D57684E-C621-423B-9568-21CB0D047999

Q34080807-494DCC3C-1EB0-48EC-85D3-72A38DF40A1C

Q34080807-49C32536-6110-4DAC-8077-C802806C2F24

Q34080807-4C54FFA1-688E-4BC3-B986-A23D5A03073D

Q34080807-5093BEDF-DFE0-48F5-86D7-5A5B2A67946D

Q34080807-52B77DD7-6239-42C0-81A0-2FF32D1C16EE

Q34080807-53AD5FB4-0831-4C3E-9F5E-1E966FE08EAE

P304

Q34080807-86CE050C-031B-48CA-A5C2-D2E4540BC059

P31

Q34080807-201A92E1-88A1-463F-BFDD-B1D82B5CE893

P356

Q34080807-18337248-BDA8-4C6E-92AB-77D75C8E9833

P407

Q34080807-8B3BC399-CAE9-4929-91A3-279747ABE298

P433

Q34080807-A91352BA-46A8-4D1C-B536-777DAE53DFB6

P478

Q34080807-40714363-568C-46AD-8AD6-6B8D805EC6DF

P50

Q34080807-369214DE-B653-4F7F-BE37-A8419109387E

Q34080807-52C275E9-F2F1-4CDE-821D-21CBE9BBC84F

Q34080807-C773C1D7-8F58-4199-9D67-477C89748ABB

Q34080807-CA102CDB-B861-457E-A1E4-CA44ECEF338B

Q34080807-CD956A8B-074A-4250-AFFF-7F3C567DEA50

Q34080807-D2D9A068-5F1A-426C-AF2B-12CD5FA9B610

Q34080807-E70BED58-06A6-49C3-AE2E-00163ADCF1A0

P577

Q34080807-14B650F0-19AC-43CA-8203-978EEADE7A1D

P5875

Q34080807-48BFA2FC-1FD8-4294-B60F-DFAB49D250B2

P698

Q34080807-6EB08308-54CA-48B3-96A0-BAE2433F79F5

P921

Q34080807-86886B4B-0BA3-4A44-AA30-CEA3150BD4E1

P932

Q34080807-CDFC93BA-1D88-4E1B-8233-048E86025853

P356

BLOOD-2009-04-215152

P1433

P1476

Novel prognostic subgroups in ...... ernational retrospective study

@en

P2093

Akira Morimoto

http://www.w3.org/2001/XMLSchema#string

Anna Leszl

http://www.w3.org/2001/XMLSchema#string

Anne Auvrignon

http://www.w3.org/2001/XMLSchema#string

Brenda Gibson

http://www.w3.org/2001/XMLSchema#string

Brian V Balgobind

http://www.w3.org/2001/XMLSchema#string

C Michel Zwaan

http://www.w3.org/2001/XMLSchema#string

Christine Perot

http://www.w3.org/2001/XMLSchema#string

David Webb

http://www.w3.org/2001/XMLSchema#string

Dirk Reinhardt

http://www.w3.org/2001/XMLSchema#string

Erik Forestier

http://www.w3.org/2001/XMLSchema#string

P2860

Oncogene AF1q enhances doxorubicin-induced apoptosis through BAD-mediated mitochondrial apoptotic pathway

The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties

Ethnicity and survival in childhood acute myeloid leukemia: a report from the Children's Oncology Group

Favorable impact of the t(9;11) in childhood acute myeloid leukemia.

Adult de novo acute myeloid leukemia with t(6;11)(q27;q23): results from Cancer and Leukemia Group B Study 8461 and review of the literature.

Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): a review of four consecutive childhood AML trials conducted between 1981 and 2000.

Outcomes in CCG-2961, a children's oncology group phase 3 trial for untreated pediatric acute myeloid leukemia: a report from the children's oncology group.

Pediatric acute myeloid leukemia: towards high-quality cure of all patients.

Monosomy 7 and deletion 7q in children and adolescents with acute myeloid leukemia: an international retrospective study.

Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: results of AML-BFM 98.

P304

2489-2496

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2009-04-215152

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

114

http://www.w3.org/2001/XMLSchema#string

P50

Daisuke Tomizawa

Christine J Harrison

Zuzana Zemanová

Jeffrey Rubnitz

P577

2009-06-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26294046

http://www.w3.org/2001/XMLSchema#string

P698

19528532

http://www.w3.org/2001/XMLSchema#string

P921

P932

2927031

http://www.w3.org/2001/XMLSchema#string